Quantcast
Last updated on April 24, 2014 at 6:16 EDT

Latest Diabetic foot Stories

2012-08-07 06:26:02

KENNESAW, Ga., Aug. 7, 2012 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has closed a clinical trial involving its EpiFix® dehydrated human amniotic membrane allograft for the treatment of diabetic neurovascular foot ulcers. This prospective trial design initially targeted 80 patients. Those patients...

2012-08-06 06:24:24

CHICAGO, Aug. 6, 2012 /PRNewswire-USNewswire/ -- The second annual meeting of the American College of Wound Healing and Tissue Repair (ACWHTR), held from July 26-28, 2012, featured a multidisciplinary faculty of opinion leaders who addressed scientific breakthroughs, clinical research developments, and policy and regulatory issues that will change the landscape of modern wound care. "The ACWHTR annual meeting is distinct from all other meetings in wound care," commented Dr. William Ennis,...

2012-08-01 02:28:51

SAN DIEGO, Aug. 1, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced that its professional-use Excellagen® (formulated collagen gel 2.6%) wound care product was selected as one of the top ten podiatry innovations in 2012 by the publication Podiatry Today. The Company also announced that it will be introducing Excellagen at the American Podiatric Medical Association (APMA) National Meeting (Booth 1910) being held August 16 - 19, 2012 in Washington, DC. (Logo:...

2012-07-11 10:23:13

SAN ANTONIO, July 11, 2012 /PRNewswire-iReach/ -- Electrochemical Oxygen Concepts (EO2(TM) Concepts) announced today that it has been awarded a group purchasing agreement with the Premier Healthcare Alliance for its new wound care therapy device. The new agreement allows Premier members to take advantage of special pricing and terms pre-negotiated by Premier for the TransCu O2(®) device. (Photo: http://photos.prnewswire.com/prnh/20120711/CG38834) "We are proud to be represented by...

2012-06-07 02:27:48

NORTHVALE, N.J., June 7, 2012 /PRNewswire/ -- Orthofeet, a leading designer and manufacturer of biomechanically designed footwear, announced the showcasing of their portfolio of therapeutic and casual shoes at the American Diabetes Association (ADA) 72nd Scientific Sessions in Philadelphia, June 9-11. "Our presence at this meeting - the world's largest diabetes conference -- supports Orthofeet's corporate vision to improve mobility and quality of life for adults with this...

2012-05-24 10:24:00

SAN ANTONIO, May 24, 2012 /PRNewswire-iReach/ -- An advisory board of industry leaders at the 2012 Texas Life Science Venture Forum in Houston, Texas namedTransCU O2®, a cutting-edge therapy for chronic wounds, one of ten Most Promising Life Science Technologies. Over 60 companies were invited to present their research and innovations to hundreds of early-stage investors, venture capitalists, and industry leaders. This award represents another important achievement for Electrochemical...

2012-05-22 11:30:15

IDSA diabetic foot infection guidelines suggest multidisciplinary team approach is best AT A GLANCE Diabetic foot complications are the most common cause of lower extremity amputations and half of all patients who have a foot amputated die within five years. Most amputations can be prevented with proper care of diabetic foot infections, suggest new guidelines released by the Infectious Diseases Society of America (IDSA). A multi-disciplinary team — including infectious diseases...

2012-04-19 14:21:50

SAN DIEGO, April 19, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) is currently exhibiting its new FDA-cleared Excellagen(®) professional-use, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers and other dermal wounds at the 2012 Spring Symposium on Advanced Wound Care (SAWC) being held April 19 - 22, 2012 in Atlanta, GA. (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) The 2012 Spring SAWC provides Cardium an...

2012-04-17 02:28:44

CANTON, Mass., April 17, 2012 /PRNewswire/ -- Today Organogenesis Inc., a business leader in the regenerative medicine field, announced that Apligraf® has established improved coverage from multiple payors, improving access to care for millions of patients suffering from chronic, non-healing wounds. Apligraf is the only cell-based product with FDA approval for the treatment of both diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). National Government Services, one of the...

2012-03-29 22:00:30

A simple test to identify MRSA in wounds could identify the superbug quickly and help prevent infection from spreading. Scientists have developed the test to show whether wounds or lesions are infected with bacteria and if MRSA is present. Test The test, developed at the University of Edinburgh in collaboration with NHS Lothian, works by taking swabs from a wound or sores. These are then analyzed using a strip with electrical sensors that can detect MRSA. Researchers currently...